Gel
You are viewing 123 results

ID-Partial RhD Typing Set
ID-Anti-D kit for the typing of partial RhD

DiaClon ABO/Rh for Donors
Complete donor test profile for forward typing of ABO plus RhD and CDE in a single test procedure

ID-DiaCell I-II-III Asia (Miᵃ+)
Three-cell screening for patients containing a set of 3 vials for IAT and NaCI testing

ID-Diluent 1
Modified Bromelin solution for red cell suspension and enzyme tests

LISS/Coombs
ID-Card of 6 microtubes containing anti-human globulin anti-IgG (rabbit) and C3d

Anti-A₁ Absorbed
Reagent Anti-A₁ Absorbed agglutinates A₁ cells but reacts negatively or only weakly with A₂ cells

DiaClon ABO/Rh for Newborns DVI-
ID-Card with monoclonal anti-D selected so as to not react with DVI variants

ID-DiaCell I-II-III
Three-cell screening panel for patients containing a set of 3 vials for IAT and NaCI testing

ID-Diluent 2
Modified low-ionic strength solution for red cell suspensions

NaCl, Enzyme Test and Cold Agglutinins
ID-Card for antibody screening and identification, compatibility testing and reverse grouping

DiaClon Anti-H
ID-Card with 6 microtubes containing anti-H, monoclonal, within the gel matrix

DiaClon ABO/Rh for Newborns DVI+
ABO/Rh for newborns DVI+ using monoclonal antisera. The anti-D used will not react with all examples of Dweak

IH-QC 1
The IH-QC Modular System is a compact and flexible solution, covering different guidelines

ID-DiaCell IP-IIP-IIIP
Three-cell screening for patients (papainized), containing a set of 3 vials for enzyme test procedures

Coombs Anti-IgG
ID-Card containing 6 microtubes containing anti-human globulin anti-IgG (rabbit)

DiaClon ABO/Rh for Patients
ID-Card for forward typing of ABO, plus RhD (DVI neg.) and CDE, in a single test procedure

IH-QC 2
The IH-QC Modular System is a compact and flexible solution, covering different guidelines

ID-DiaCell Pool
Two pooled cells for IAT donor screening

Coombs Anti-IgG
ID-Card of 6 microtubes containing anti-human globulin anti-IgG (rabbit)

DAT IgG1/IgG3
ID-Card containing two dilutions of both anti-IgG1 and IgG3, used to differentiate between low and high risk for hemolysis